PAHSA lipids are a family of anti-inflammatory lipids that have been found to play an important role in metabolic health. PAHSA stands for palmitic acid hydroxystearic acid, which refers to the chemical structure of these lipids. Research has shown that PAHSA lipids help to regulate insulin sensitivity, glucose uptake, and inflammation in the body. They are produced by adipose tissue and have been identified in various tissues throughout the body, such as the liver, brain, and skeletal muscle. Studies have found that individuals with obesity and type 2 diabetes have lower levels of PAHSA lipids in their blood, suggesting that they may be a potential therapeutic target for these conditions. Furthermore, animal studies have shown that increasing PAHSA lipid levels can improve insulin sensitivity and lower inflammation. In conclusion, PAHSA lipids are a promising area of research for their potential roles in metabolic health and as a target for therapies for obesity and type 2 diabetes.
CD Bioparticles’ services with customized delivery strategies, precise designs and modifications of drugs or drug-contained cargos, and advanced technical platforms can help you to solve:
|Product Name||Catalog||Form||Unit Size||Price|
|16:0-(12-PAHSA) PC||CDLP-A226||Powder||5 mg||INQUIRY|
Drug Delivery Nanoparticles Formulation
Bioparticles Analysis and Characterization
Bioactive Particles & Fillers Production
Functional Biomedical Coatings